-
1
-
-
0033739654
-
Smoking and mental illness: A population-based prevalence study
-
Lasser KAA, Boyd JW, Woolhandler S, et al. Smoking and mental illness: A population-based prevalence study. JAMA 2000;284:2606-10.
-
(2000)
JAMA
, vol.284
, pp. 2606-10
-
-
Lasser, K.1
Boyd, J.W.2
Woolhandler, S.3
-
2
-
-
0028901714
-
Schizophrenia and smoking: An epidemiological survey in a state hospital
-
De Leon J, Dadvand M, Canuso C, et al. Schizophrenia and smoking: An epidemiological survey in a state hospital. Am J Psychiatry 1995;152:453-5.
-
(1995)
Am. J. Psychiatry
, vol.152
, pp. 453-5
-
-
De Leon, J.1
Dadvand, M.2
Canuso, C.3
-
3
-
-
35348960372
-
Severe mental illness and risk of cardiovascular disease
-
Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA 2007;298:1794-6.
-
(2007)
JAMA
, vol.298
, pp. 1794-6
-
-
Newcomer, J.W.1
Hennekens, C.H.2
-
4
-
-
33747512902
-
Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: A preventive perspective
-
Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: A preventive perspective. Harv Rev Psychiatry 2006;14:212-22.
-
(2006)
Harv Rev. Psychiatry
, vol.14
, pp. 212-22
-
-
Compton, M.T.1
Daumit, G.L.2
Druss, B.G.3
-
5
-
-
0025190458
-
Sensorimotor gating and schizophrenia: Human and animal model studies
-
Braff DL, Geyer M. Sensorimotor gating and schizophrenia: Human and animal model studies. Arch Gen Psychiatry 1990;47:181-8.
-
(1990)
Arch. Gen. Psychiatry
, vol.47
, pp. 181-8
-
-
Braff, D.L.1
Geyer, M.2
-
6
-
-
0036897309
-
Association of promoter variants in the a7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia
-
Leonard S, Gault J, Hopkins J, et al. Association of promoter variants in the a7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002;59:1085-96.
-
(2002)
Arch. Gen. Psychiatry
, vol.59
, pp. 1085-96
-
-
Leonard, S.1
Gault, J.2
Hopkins, J.3
-
7
-
-
57349116210
-
Nicotine self-medication of cognitive-attentional processing
-
Evans DE, Drobes DJ. Nicotine self-medication of cognitive-attentional processing. Addict Biol 2008;14:32-42.
-
(2008)
Addict Biol.
, vol.14
, pp. 32-42
-
-
Evans, D.E.1
Drobes, D.J.2
-
8
-
-
62649110745
-
Increased antibodies for the a-7 subunit of the nicotinic receptor in schizophrenia
-
Chandley MJ, Miller MN, Newell-Kwasigrich C, et al. Increased antibodies for the a-7 subunit of the nicotinic receptor in schizophrenia. Schizophr Res 2009;109:98-101.
-
(2009)
Schizophr Res.
, vol.109
, pp. 98-101
-
-
Chandley, M.J.1
Miller, M.N.2
Newell-Kwasigrich, C.3
-
9
-
-
0027380988
-
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
-
Adler LE, Hoffer LD, Wiser A, et al. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 1993;150:1856-61.
-
(1993)
Am. J. Psychiatry
, vol.150
, pp. 1856-61
-
-
Adler, L.E.1
Hoffer, L.D.2
Wiser, A.3
-
10
-
-
0034944227
-
Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia
-
Kumari V, Soni W, Sharma T. Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol 2001;16:321-6.
-
(2001)
Hum Psychopharmacol
, vol.16
, pp. 321-6
-
-
Kumari, V.1
Soni, W.2
Sharma, T.3
-
11
-
-
0034732116
-
Smoking and schizophrenia: Abnormal nicotinic receptor expression
-
Leonard S, Breese C, Adams C, et al. Smoking and schizophrenia: Abnormal nicotinic receptor expression. Eur J Pharmacol 2000;393:237-42.
-
(2000)
Eur. J. Pharmacol.
, vol.393
, pp. 237-42
-
-
Leonard, S.1
Breese, C.2
Adams, C.3
-
12
-
-
77952148672
-
Schizophrenia and other psychotic disorders
-
Kneisl C, Trigoboff E, eds, 2nd ed. Upper Saddle River, NJ: Prentice Hall
-
Trigoboff E. Schizophrenia and other psychotic disorders. In: Kneisl C, Trigoboff E, eds. Contemporary psychiatricmental health nursing, 2nd ed. Upper Saddle River, NJ: Prentice Hall; 2009: 370-403.
-
(2009)
Contemporary Psychiatricmental Health Nursing
, pp. 370-403
-
-
Trigoboff, E.1
-
13
-
-
84978743958
-
Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states
-
Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006; 3: A42.
-
(2006)
Prev Chronic Dis.
, vol.3
-
-
Colton, C.W.1
Manderscheid, R.W.2
-
14
-
-
68949172254
-
11-year followup of mortality in patients with schizophrenia: A population-based cohort study
-
Tiihonen J, Lönnqvist J, Wahlbeck K, et al. 11-year followup of mortality in patients with schizophrenia: A population-based cohort study. Lancet 2009;374:620-7.
-
(2009)
Lancet
, vol.374
, pp. 620-7
-
-
Tiihonen, J.1
Lönnqvist, J.2
Wahlbeck, K.3
-
15
-
-
34948840329
-
Meta-Analysis-A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?
-
Saha S, Chant D, McGrath J. Meta-Analysis-A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-31.
-
(2007)
Arch. Gen. Psychiatry
, vol.64
, pp. 1123-31
-
-
Saha, S.1
Chant, D.2
McGrath, J.3
-
16
-
-
47749140753
-
Metabolism of atypical antipsychotics: Involvement of Cytochrome P450 enzymes and relevance for drug-drug interactions
-
Urichuk L, Prior TI, Dursun S, et al. Metabolism of atypical antipsychotics: Involvement of Cytochrome P450 enzymes and relevance for drug-drug interactions. Curr Drug Metab 2008;9:410-8.
-
(2008)
Curr. Drug Metab.
, vol.9
, pp. 410-8
-
-
Urichuk, L.1
Prior, T.I.2
Dursun, S.3
-
17
-
-
0033055995
-
Drug interactions with tobacco smoking. An update
-
Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999;36:425-38.
-
(1999)
Clin. Pharmacokinet
, vol.36
, pp. 425-38
-
-
Zevin, S.1
Benowitz, N.L.2
-
18
-
-
34548806494
-
Clinical review: Drug interactions with smoking
-
Kroon LA. Clinical review: Drug interactions with smoking. Am J Health Syst Pharm 2007;64:1917-21.
-
(2007)
Am. J. Health Syst Pharm.
, vol.64
, pp. 1917-21
-
-
Kroon, L.A.1
-
19
-
-
1642457270
-
Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: A predictive model and nomograms to aid compliance in individual patients
-
Rostami-Hodjegan A, Amin AM, Spencer EP, et al. Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: A predictive model and nomograms to aid compliance in individual patients. J Clin Psychopharmacol 2004;24:70-8.
-
(2004)
J. Clin. Psychopharmacol
, vol.24
, pp. 70-8
-
-
Rostami-Hodjegan, A.1
Amin, A.M.2
Spencer, E.P.3
-
20
-
-
0024468418
-
Dose-related plasma levels of clozapine: Influence of smoking behaviour, sex and age
-
Haring C, Meise U, Humpel C, et al. Dose-related plasma levels of clozapine: Influence of smoking behaviour, sex and age. Psychopharmacology 1989; 99: S38-S40.
-
(1989)
Psychopharmacology
, vol.99
-
-
Haring, C.1
Meise, U.2
Humpel, C.3
-
21
-
-
0029969184
-
Pharmacokinetics and drug interactions: Update for new antipsychotics
-
Ereshefsky L. Pharmacokinetics and drug interactions: Update for new antipsychotics. J Clin Psychiatry 1996;57:12-25.
-
(1996)
J. Clin. Psychiatry
, vol.57
, pp. 12-25
-
-
Ereshefsky, L.1
-
22
-
-
0035195730
-
Individual changes in clozapine levels after smoking cessation: Results and a predictive model
-
Meyer JM. Individual changes in clozapine levels after smoking cessation: Results and a predictive model. J Clin Psychopharmacology 2001;21:569-74.
-
(2001)
J. Clin. Psychopharmacology
, vol.21
, pp. 569-74
-
-
Meyer, J.M.1
-
23
-
-
23244442895
-
Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients
-
Bondolfi G, Morel F, Crettol S, et al. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients. Ther Drug Monit 2005;27:539-43.
-
(2005)
Ther. Drug Monit
, vol.27
, pp. 539-43
-
-
Bondolfi, G.1
Morel, F.2
Crettol, S.3
-
24
-
-
0037339287
-
The effect of smoking and cytochrome p450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement
-
van der Weide J, Steijns LSW, van Weelden MJM. The effect of smoking and cytochrome p450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. Pharmacogenetics 2003;13:169-72.
-
(2003)
Pharmacogenetics
, vol.13
, pp. 169-72
-
-
Van Der Weide, J.1
Steijns, L.S.W.2
Van Weelden, M.J.M.3
-
25
-
-
33751252806
-
The effect of variable cigarette consumption on the interaction with clozapine and olanzapine
-
Haslemo T, Haakon-Eikeseth P, Tanum L, et al. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine. Eur J Clin Pharmacol 2006;62:1049-53.
-
(2006)
Eur. J. Clin. Pharmacol.
, vol.62
, pp. 1049-53
-
-
Haslemo, T.1
Haakon-Eikeseth, P.2
Tanum, L.3
-
26
-
-
0036238160
-
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine
-
Zullino DF, Delessert D, Eap CB, et al. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol 2002;17:141-3.
-
(2002)
Int. Clin. Psychopharmacol
, vol.17
, pp. 141-3
-
-
Zullino, D.F.1
Delessert, D.2
Eap, C.B.3
-
27
-
-
26844507816
-
Clozapine toxicity associated with smoking cessation: Case report
-
Derenne JL, Baldessarini RJ. Clozapine toxicity associated with smoking cessation: Case report. Am J Ther 2005; 12; 469-71.
-
(2005)
Am. J. Ther.
, vol.12
, pp. 469-71
-
-
Derenne, J.L.1
Baldessarini, R.J.2
-
28
-
-
0002370297
-
The Brief Psychiatric Rating Scale (BPRS) : Recent developments in ascertainment and scaling
-
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS) : Recent developments in ascertainment and scaling. Psychopharmacol Bull 1988;24:97-9.
-
(1988)
Psychopharmacol Bull.
, vol.24
, pp. 97-9
-
-
Overall, J.E.1
Gorham, D.R.2
-
29
-
-
0004235298
-
-
American Psychiatric Association. Global Assessment of Functioning scale. In:, 4th edition, text revision. Washington, DC: American Psychiatric Association
-
American Psychiatric Association. Global Assessment of Functioning scale. In: Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000: 32-4.
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
, pp. 32-4
-
-
-
30
-
-
77952203593
-
NYS OMH SPAN Initiative
-
available from author on request
-
Gonzalez ML, Demler TL. NYS OMH SPAN Initiative. Inside OMH medication update. 2007;2:1 (1-4) (available from author on request).
-
(2007)
Inside OMH Medication Update
, vol.2
, Issue.1-4
, pp. 1
-
-
Gonzalez, M.L.1
Demler, T.L.2
-
31
-
-
33748800996
-
Clozapine use and relapses of substance use disorder among patients with cooccurring schizophrenia and substance use disorders
-
Brunette MF, Drake RF, Xie H, et al. Clozapine use and relapses of substance use disorder among patients with cooccurring schizophrenia and substance use disorders. Schizophr Bull 2006;32:637-43.
-
(2006)
Schizophr Bull.
, vol.32
, pp. 637-43
-
-
Brunette, M.F.1
Drake, R.F.2
Xie, H.3
-
32
-
-
0028151321
-
Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: A case report and a hypothesis
-
Yovell Y, Opler LA. Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: A case report and a hypothesis. J Nerv Ment Dis 1994;182:591-2.
-
(1994)
J. Nerv Ment Dis.
, vol.182
, pp. 591-2
-
-
Yovell, Y.1
Opler, L.A.2
-
33
-
-
0034830198
-
A comparison of smoking behaviors between patients treated with clozapine and depot neuroleptics
-
Procyshyn RM, Ihsan N, Thompson D. A comparison of smoking behaviors between patients treated with clozapine and depot neuroleptics. Int Clin Psychopharmacol 2001;16:291-4.
-
(2001)
Int. Clin. Psychopharmacol
, vol.16
, pp. 291-4
-
-
Procyshyn, R.M.1
Ihsan, N.2
Thompson, D.3
-
34
-
-
0036152014
-
Concomitant clozapine reduces smoking in patients treated with risperidone
-
Procyshyn RM, Tse G, Sin O, et al. Concomitant clozapine reduces smoking in patients treated with risperidone. Eur Neuropsychopharmacol 2002;12:77-80.
-
(2002)
Eur. Neuropsychopharmacol
, vol.12
, pp. 77-80
-
-
Procyshyn, R.M.1
Tse, G.2
Sin, O.3
-
35
-
-
0028314023
-
Decreased substance use in chronically psychotic patients treated with clozapine
-
Albanese MJ, Khantzian EJ, Murphy SL, et al. Decreased substance use in chronically psychotic patients treated with clozapine. Am J Psychiatry 1994;151:780-1.
-
(1994)
Am. J. Psychiatry
, vol.151
, pp. 780-1
-
-
Albanese, M.J.1
Khantzian, E.J.2
Murphy, S.L.3
-
36
-
-
0033955215
-
Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey
-
Zimmet SV, Strous RD, Burgess ES, et al. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey. J Clin Psychopharmacol 2000;20:94-8.
-
(2000)
J. Clin. Psychopharmacol
, vol.20
, pp. 94-8
-
-
Zimmet, S.V.1
Strous, R.D.2
Burgess, E.S.3
-
37
-
-
0037333663
-
Alcohol and cannabis use in schizophrenia: Effects of clozapine and risperidone
-
Green AI, Burgess ES, Zimmet SV, et al. Alcohol and cannabis use in schizophrenia: Effects of clozapine and risperidone. Schizophr Res 2003;60:81-5.
-
(2003)
Schizophr Res.
, vol.60
, pp. 81-5
-
-
Green, A.I.1
Burgess, E.S.2
Zimmet, S.V.3
-
38
-
-
0000742319
-
Clozapine treatment of comorbid substance abuse in patients with schizophrenia
-
Buckley P, McCarthy M, Chapman P, et al. Clozapine treatment of comorbid substance abuse in patients with schizophrenia. Schizophr Res 1999;36:272.
-
(1999)
Schizophr Res.
, vol.36
, pp. 272
-
-
Buckley, P.1
McCarthy, M.2
Chapman, P.3
-
39
-
-
0033918990
-
The effects of clozapine on alcohol and drug use disorders among schizophrenic patients
-
Drake RE, Xie H, McHugo GJ, et al. The effects of clozapine on alcohol and drug use disorders among schizophrenic patients. Schizophr Bull 2000;26:441-9.
-
(2000)
Schizophr Bull.
, vol.26
, pp. 441-9
-
-
Drake, R.E.1
Xie, H.2
McHugo, G.J.3
-
40
-
-
0023606101
-
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
-
Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
-
(1987)
Schizophr Bull.
, vol.13
, pp. 261-76
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
|